1. Home
  2. RVP vs MRKR Comparison

RVP vs MRKR Comparison

Compare RVP & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Retractable Technologies Inc.

RVP

Retractable Technologies Inc.

N/A

Current Price

$0.67

Market Cap

21.0M

Sector

Health Care

ML Signal

N/A

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

N/A

Current Price

$1.51

Market Cap

23.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVP
MRKR
Founded
1994
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
23.0M
IPO Year
2000
2010

Fundamental Metrics

Financial Performance
Metric
RVP
MRKR
Price
$0.67
$1.51
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.25
AVG Volume (30 Days)
35.9K
145.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,049,533.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$0.81
52 Week High
$1.14
$4.07

Technical Indicators

Market Signals
Indicator
RVP
MRKR
Relative Strength Index (RSI) 54.84 47.67
Support Level $0.63 $1.36
Resistance Level $0.72 $1.88
Average True Range (ATR) 0.04 0.12
MACD 0.01 0.00
Stochastic Oscillator 92.02 43.24

Price Performance

Historical Comparison
RVP
MRKR

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: